Vetter’s State-of-the-Art Chicago Facility is Fully Operational
Designed specifically for early clinical-stage, high-value biopharmaceuticals, Vetter’s new automated vial filler can run up to 10,000 liquid or 6,000 lyophilized vials per batch.
Intended for liquid fills, a second cleanroom houses a flexible semi-automated filler. The system can fill a variety of packaging materials – syringes, cartridges and vials – with a capacity of up to 500 units per batch.
Both automated and semi-automated units provide a 100 percent in-line check-weigh system, which helps ensure accurate fill volume – critical in small, early-stage fills. Because no sampling is required to verify fill volume, the system increases API yield.
The facility uses exclusively disposable components in material preparation, compounding and filtration areas, which eliminates the need for cleaning validation – and thus saves valuable time and cost.
A third cleanroom will expand current operations and provide filling of pre-sterilized syringes.
Said Vetter Managing Director Peter Soelkner, “Our Chicago facility provides customers with a top-of-the-line clinical manufacturing site located in the heart of the United States . Because Vetter consistently strives to stay at the forefront of innovation, securing Bosch’s new fully automated vial filler was a natural for us. Here in Chicago, our state-of-the-art systems and infrastructure, coupled with our professional expertise, offer customers the quality they expect from Vetter.“
Other news from the department manufacturing
Most read news
More news from our other portals
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.